Bill > A05285

This bill modifies prescription label requirements for two specific medications, mifepristone and misoprostol (which are commonly used for medication abortion), by allowing more flexibility in how healthcare practices identify themselves on prescription labels. Specifically, the bill permits prescription labels to include the name or address of the dispensing healthcare practice instead of the individual dispenser's name, and allows prescribing healthcare practices to request that their name or address be used on the label instead of the individual prescriber's name. Additionally, the bill mandates that when a healthcare prescriber chooses to use the practice's name or address instead of their personal information, they must inform the patient about this choice. These changes appear designed to provide additional privacy and potentially safety protections for healthcare providers who prescribe these specific medications, which have been particularly sensitive in the current reproductive healthcare landscape. The bill will take effect simultaneously with a related 2025 amendment to the education law concerning medication labeling.

Education

https://www.nysenate.gov/legislation/bills/2025/A5285